The researchers explained, Since GLP-1 class obesity drugs appear to have a substantial impact on endometrial cancer incidence, we are currently investigating the mechanisms by which they affect endometrial cancer growth and prognosis, adding, We are analyzing the molecular pathways regulated by these drugs. They continued, Because a causal relationship has not yet been established, GLP-1 class drugs should not be used solely for the purpose of reducing cancer risk, and added, As the use of GLP-1 class drugs increases worldwide, it is becoming ever more important to understand their broad effects on health. doi.org/10.1016/j.annonc.2026.04.013
PSA Men with obesity have been found to have lower serum levels of prostate specific antigen (PSA) than non-obese men of the same age
(Symptomatic uncomplicated cholelithiasis) or enforced him to seek interventions e.g., cholecystectomy, acute pancreatitis, obstructive jaundice, or cirrhosis (Symptomatic complicated cholelithiasis)
The trial was 12 weeks
UHC has expanded coverage for obesity-related conditions, and many plans now include GLP-1 medications
Q: Can IV Therapy help with pre- and post-performance recovery support
